Status:
NOT_YET_RECRUITING
Effectiveness of Curcuminoids in Controlling Postoperative Pain Following Total Laparoscopic Hysterectomy
Lead Sponsor:
Erzincan Military Hospital
Conditions:
Postoperative Care
Pain Management
Eligibility:
FEMALE
20-80 years
Phase:
PHASE4
Brief Summary
Total hysterectomy is one of the most common surgical procedures in gynecology. Total laparoscopic hysterectomy (TLH) has several advantages over open surgery, such as better cosmetic outcomes, faster...
Eligibility Criteria
Inclusion
- Laparoscopic total hysterectomy and salpingectomy, with the option of additional procedures such as oophorectomy, uterosacral ligament plications, trans obturator tape insertion, or sentinel lymphadenectomy candidates
- They should be able to understand and sign an informed consent
- They should be literate enough to understand the maintenance of a diary recording pain scores, QoL-15 scores, and any adverse event
Exclusion
- Patients with any peripheral or central neuropathic pain
- Patients used to taking over-the-counter painkiller pills
- Patients with a history of alcohol intake/drug dependence
- Patients with a history of psychosis
- \*Patients with chronic inflammatory diseases who cannot be taken off nonsteroidal anti-inflammatory drugs (NSAIDs)/painkillers
- Patients on immunosuppressive/cytotoxic/steroid therapy. \*Patients with a known allergy to duloxetine
Key Trial Info
Start Date :
March 21 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 15 2026
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT06886035
Start Date
March 21 2025
End Date
January 15 2026
Last Update
March 20 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.